Photo of Jeff Vacirca from nycancer.com
Jul 22, 2024, 22:56
Jeff Vacirca: We couldn’t be more proud to support Thyme Care with their Series C announcement
Jeff Vacirca, CEO at New York Cancer and Blood Specialists, shared a post on LinkedIn:
”Cancer is costly and complex to manage, and while there have been incredible feats of scientific and medical breakthroughs, little innovation to the cancer care experience has been made until now. Thyme Care is transforming the experience and reducing costs for cancer patients across the care continuum, and we couldn’t be more proud to support them with their Series C announcement. Read more here.”
Source: Jeff Vacirca/LinkedIn
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 4, 2025, 05:26
Aug 4, 2025, 05:17
Aug 4, 2025, 01:19
Aug 3, 2025, 20:42
Aug 3, 2025, 20:04
Aug 3, 2025, 19:45
Aug 3, 2025, 19:32